Parameters of antioxidant protection in patients with lung sarcoidosis Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009
The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Role of antioxidant in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001
Monitoring antioxidant enzyme activity in patients with COPD exacerbations Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Lipid peroxidation and antioxidative enzymes in patients with COPD: relationship to pulmonary hyperinflation Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Altered expression of CuZn-SOD and thioredoxin correlate with the histopathological features in small airways of patients with severe COPD Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015
Procoagulant and antifibrynolitic activities strongly correlate with fibrosis and tissue turn-over markers in patients with active idiopathic pulmonary fibrosis and hypersensitivity pneumonitis Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
Reduced anti-oxidant and increased inflammatory status in interstitial lung diseases (ILD) Source: Eur Respir J 2007; 30: Suppl. 51, 110s Year: 2007
Rosuvastatin effects on systemic inflammation, oxidative stress and antioxidants in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016
Inflammatory markers and HDAC activity in induced sputum of smokers and COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
Relationship between peroxidation and antioxidant status in induced sputum and BODE-index in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009
Monitoring oxidative stress in the lung: Changes in superoxide dismutase (SOD) activity during the course of acute exacerbations in COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Effect of smoking on the antioxidant defense and lipid peroxidation in patients with chronic obstructive bronchitis Source: Eur Respir J 2003; 22: Suppl. 45, 306s Year: 2003
Effect of smoking on antioxidant defence and lipid peroxidation in patients with chronic obstructive bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 390s Year: 2005
Oxidant stress in idiopathic pulmonary fibrosis. Study of the antioxidants SOD enzymes by molecular and immunohistochemical analysis Source: Eur Respir J 2007; 30: Suppl. 51, 587s Year: 2007
The effects of antioxidant therapy on lung clearance, pulmonary function test and oxidant stress in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Correlation between physical activity and prognostic markers in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020